Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirják L, Derksen R, Dörner T, Gordon C, Graninger W, Houssiau F, Inanc M, Jacobsen S, Jayne D, Jedryka-Goral A, Levitsky A, Levy R, Mariette X, Morand E, Navarra S, Neumann I, Rahman A, Rovensky J, Smolen J, Vasconcelos C, Voskuyl A, Voss A, Zakharova H, Zoma A, Schneider M.

Ann Rheum Dis. 2014 Jun;73(6):958-67. doi: 10.1136/annrheumdis-2013-205139. Epub 2014 Apr 16.

PMID:
24739325
[PubMed - indexed for MEDLINE]
Free Article
2.

Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.

Fanouriakis A, Mastorodemos V, Pamfil C, Papadaki E, Sidiropoulos P, Plaitakis A, Amoiridis G, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2014 Jun;43(6):751-8. doi: 10.1016/j.semarthrit.2013.11.007. Epub 2013 Nov 13.

PMID:
24332007
[PubMed - in process]
3.

Steroid-induced diabetes in rheumatologic patients.

Angelopoulos TP, Tentolouris NK, Bertsias GK, Boumpas DT.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):126-30. Epub 2013 Oct 17.

PMID:
24143933
[PubMed - in process]
4.

Programmed death 1 and B and T lymphocyte attenuator immunoreceptors and their association with malignant T-lymphoproliferative disorders: brief review.

Karakatsanis S, Bertsias G, Roussou P, Boumpas D.

Hematol Oncol. 2013 Sep 13. doi: 10.1002/hon.2098. [Epub ahead of print]

PMID:
24038528
[PubMed - as supplied by publisher]
5.

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival.

Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, Zisopoulos D, Skopouli FN, Iliopoulos A, Bertsias GK, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P.

Semin Arthritis Rheum. 2014 Feb;43(4):447-57. doi: 10.1016/j.semarthrit.2013.07.011. Epub 2013 Sep 6.

PMID:
24012040
[PubMed - in process]
6.

Gene expression and regulation in systemic lupus erythematosus.

Frangou EA, Bertsias GK, Boumpas DT.

Eur J Clin Invest. 2013 Oct;43(10):1084-96. doi: 10.1111/eci.12130. Epub 2013 Jul 31. Review.

PMID:
23902282
[PubMed - indexed for MEDLINE]
7.

Diagnostic criteria for systemic lupus erythematosus: has the time come?

Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT.

Nat Rev Rheumatol. 2013 Nov;9(11):687-94. doi: 10.1038/nrrheum.2013.103. Epub 2013 Jul 9.

PMID:
23838616
[PubMed - indexed for MEDLINE]
8.

Pathogenesis and treatment of CNS lupus.

Fanouriakis A, Boumpas DT, Bertsias GK.

Curr Opin Rheumatol. 2013 Sep;25(5):577-83. doi: 10.1097/BOR.0b013e328363eaf1. Review.

PMID:
23836074
[PubMed - indexed for MEDLINE]
9.

WITHDRAWN: Use of mycophenolic acid in lupus nephritis.

Bertsias GK, Boumpas DT.

Clin Immunol. 2013 Jan 6. pii: S1521-6616(12)00310-5. doi: 10.1016/j.clim.2012.12.010. [Epub ahead of print]

PMID:
23375661
[PubMed - as supplied by publisher]
10.

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.

Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, Emrence Z, Cakar A, Abaci N, Ustek D, Satorius C, Ueda A, Takeno M, Kim Y, Wood GM, Ombrello MJ, Meguro A, Gül A, Remmers EF, Kastner DL.

Nat Genet. 2013 Feb;45(2):202-7. doi: 10.1038/ng.2520. Epub 2013 Jan 6.

PMID:
23291587
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.

Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, Sidiropoulos P, Boumpas DT.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):172-9. Epub 2012 Nov 6.

PMID:
23137515
[PubMed - indexed for MEDLINE]
12.

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association.

Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.

PMID:
22851469
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis.

Moysiadis DK, Perysinaki GS, Bertsias G, Stratakis S, Kyriacou K, Nakopoulou L, Boumpas DT, Daphnis E.

Lupus. 2012 Oct;21(11):1196-207. doi: 10.1177/0961203312451784. Epub 2012 Jul 5. Erratum in: Lupus. 2013 Jul;22(8):868.

PMID:
22767414
[PubMed - indexed for MEDLINE]
14.

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.

Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, Kardassis D, Boumpas DT, Sidiropoulos PI.

Arthritis Res Ther. 2012 Jun 12;14(3):R141. doi: 10.1186/ar3874.

PMID:
22691241
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Validation of the Greek translation of the obesity-specific Moorehead-Ardelt Quality-of-Life Questionnaire II.

Charalampakis V, Daskalakis M, Bertsias G, Papadakis JA, Melissas J.

Obes Surg. 2012 May;22(5):690-6. doi: 10.1007/s11695-012-0628-x.

PMID:
22411571
[PubMed - indexed for MEDLINE]
16.

Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.

Fanouriakis A, Boumpas DT, Bertsias GK.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):437-51. doi: 10.1586/ecp.11.23. Review.

PMID:
22114854
[PubMed - indexed for MEDLINE]
17.

A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.

Vazgiourakis VM, Zervou MI, Choulaki C, Bertsias G, Melissourgaki M, Yilmaz N, Sidiropoulos P, Plant D, Trouw LA, Toes RE, Kardassis D, Yavuz S, Boumpas DT, Goulielmos GN.

Ann Rheum Dis. 2011 Dec;70(12):2184-90. doi: 10.1136/ard.2010.146530. Epub 2011 Sep 12.

PMID:
21914625
[PubMed - indexed for MEDLINE]
18.

Infections in traumatic brain injury patients.

Kourbeti IS, Vakis AF, Papadakis JA, Karabetsos DA, Bertsias G, Filippou M, Ioannou A, Neophytou C, Anastasaki M, Samonis G.

Clin Microbiol Infect. 2012 Apr;18(4):359-64. doi: 10.1111/j.1469-0691.2011.03625.x. Epub 2011 Aug 18.

PMID:
21851488
[PubMed - indexed for MEDLINE]
19.

Connective tissue diseases: Lupus nephritis-winning a few battles but not the war.

Bertsias GK, Boumpas DT.

Nat Rev Rheumatol. 2011 Jun 21;7(8):441-2. doi: 10.1038/nrrheum.2011.88. No abstract available.

PMID:
21691329
[PubMed - indexed for MEDLINE]
20.

Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.

Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, Iliopoulos D, Boumpas DT.

Ann Rheum Dis. 2011 Aug;70(8):1496-506. doi: 10.1136/ard.2010.139857. Epub 2011 May 20.

PMID:
21602271
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk